Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

Rupesh Agrawal; Ilaria Testi; Cecilia S Lee; Edmund Tsui; Marian Blazes; Jennifer E Thorne; Annabelle A Okada; Justine R Smith; Peter J McCluskey; John H Kempen; Christoph Tappeiner; Manisha Agarwal; Bahram Bodaghi; Quan Dong Nguyen; Vishali Gupta; Marc D De Smet; Manfred Zierhut; Carlos Pavesio

doi:10.1136/bjophthalmol-2020-316776

Article info

Clinical science

Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

Authors

Rupesh Agrawal National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore Singapore Eye Research Institute, Singapore, Singapore School of Material Science and Engineering, Nanyang Technological University, Singapore, Singapore Department of Medical Retina and Uveitis, Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom PubMed articles Google scholar articles
Ilaria Testi Department of Medical Retina and Uveitis, Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom PubMed articles Google scholar articles
Cecilia S Lee Department of Ophthalmology, University of Washington, Seattle, USA PubMed articles Google scholar articles
Edmund Tsui UCLA Stein Eye Institute and Department of Ophthalmology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, USA PubMed articles Google scholar articles
Marian Blazes Department of Ophthalmology, University of Washington, Seattle, USA PubMed articles Google scholar articles
Jennifer E Thorne Wilmer Eye Institute, Johns Hopkins University School of Medicine, USA, Baltimore PubMed articles Google scholar articles
Annabelle A Okada Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, New South Wales, Japan PubMed articles Google scholar articles
Justine R Smith Flinders University College of Medicine and Public Health, Adelaide, Australia PubMed articles Google scholar articles
Peter J McCluskey Department of Ophthalmology, Director Save Sight Institute, The University of Sydney, Sydney, Pennsylvania, Australia PubMed articles Google scholar articles
John H Kempen Department of Ophthalmology, Massachusetts Eye and Ear Infirmary and Harvard Medical School, Boston, USA Eye Unit, MyungSung Christian Medical Center, MCM General Hospital and MyungSung Medical School, Addis Ababa, Ethiopia PubMed articles Google scholar articles
Christoph Tappeiner Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland PubMed articles Google scholar articles
Manisha Agarwal Shroff Eye Centre, New Delhi, India PubMed articles Google scholar articles
Bahram Bodaghi Department of Ophthalmology,, Sorbonne University, Paris, France PubMed articles Google scholar articles
Quan Dong Nguyen Byers Eye Institute, Stanford Medical School, Stanford, USA PubMed articles Google scholar articles
Vishali Gupta Advanced Eye Centre, Postgraduate Institute of Medical Education (PGIMER), Chandigarh, India PubMed articles Google scholar articles
Marc D De Smet Department of Ophthalmology ZNA Middelheim, Antwerp, Belgium PubMed articles Google scholar articles
Manfred Zierhut Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany PubMed articles Google scholar articles
Carlos Pavesio Department of Medical Retina and Uveitis, Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom PubMed articles Google scholar articles
COVID-19 IMT Study Group
Google scholar articles

Correspondence to Rupesh Agrawal, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, 308433, Singapore; rupesh_agrawal{at}ttsh.com.sg Carlos Pavesio, Medical Retina and Uveitis, Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK; c.pavesio{at}nhs.net and Quan Dong Nguyen, Byers Eye Institute, Stanford University School of Medicine, California, USA; ndquan{at}stanford.edu

View Full Text

Citation

Agrawal R, Testi I, Lee CS COVID-19 IMT Study Group, et al

Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

British Journal of Ophthalmology 2021;105:639-647.

Publication history

Received May 4, 2020
Revised May 21, 2020
Accepted May 26, 2020
First published June 25, 2020.

Online issue publication

April 22, 2021

Article Versions

Previous version (22 April 2021).
Previous version (22 April 2021).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the COVID-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password